MedTech Strategist: Cleerly’s Personalized Approach to Heart Attack Risk
In this interview, Cleerly Founder and CEO, James Min, MD, shares how despite advances in cardiology, most heart attacks occur without warning....
In this interview, Cleerly Founder and CEO, James Min, MD, shares how despite advances in cardiology, most heart attacks occur without warning. Cleerly has developed a cardiology care management system based on image analysis and AI, to help clinicians personalize a patient's heart attack risk so they can determine who needs intensive management—and who doesn't.
Download the article now, to read the full interview.
Cleerly is the company creating a new standard of care for heart disease. Through value-based precision diagnostic solutions driven by machine intelligence, Cleerly enables comprehensive phenotyping of coronary artery disease, as determined from advanced non-invasive CT imaging. Led by a world-class clinical and technical team, Cleerly enhances health literacy for each and every stakeholder in the coronary care pathway. For more information, please visit: https://www.cleerlyhealth.com.
In this interview, Cleerly Founder and CEO, James Min, MD, shares how despite advances in cardiology, most heart attacks occur without warning....
Only a few months after it emerged from stealth and burst onto the medtech scene, Cleerly is already living up to its name.
Health Tech: Dr James Min On How Cleerly’s Technology Can Make An Important Impact On Our Overall WellnessAn Interview With Dave Philistin